Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane proteins and cellular components represent a broad category of molecular structures essential for the survival, structural integrity, and virulence of bacteria. This group includes the peptidoglycan cell wall, the inner cytoplasmic membrane, and, in Gram-negative bacteria, the outer membrane containing lipopolysaccharides and porins (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). These components facilitate critical biological processes such as nutrient acquisition, waste extrusion via efflux pumps, and the maintenance of osmotic pressure (Nikaido, 2003, Microbiol Mol Biol Rev). In clinical pharmacology, these structures are the primary targets for several major classes of antibiotics; for example, beta-lactams target penicillin-binding proteins (PBPs) to inhibit cell wall synthesis, while polymyxins act as detergents to disrupt membrane stability (Zasloff, 2002, Nature). Because many of these targets are unique to prokaryotic cells, they allow for selective toxicity, though the rapid evolution of these components often leads to antimicrobial resistance (Blair et al., 2015, Nat Rev Microbiol). This entry is considered a collective category rather than a single discrete therapeutic target.
Inhibition of peptidoglycan biosynthesis, disruption of cytoplasmic membrane integrity, and inhibition of membrane-bound enzymes or transport systems.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane proteins and cellular components.